About Dr. Goodman
Dr. Susan Goodman is a rheumatologist at HSS. She specializes in treatment of patients with inflammatory arthritis such as rheumatoid arthritis, psoriatic arthritis, and spondylarthritis. Her other areas of specialization is in the perioperative care of patients with rheumatic diseases.
Research interests have focused on the perioperative outcomes of rheumatic disease patients undergoing arthroplasty, racial health care disparities, and inflammatory arthritis.
Profile Video
Departments
Specialized Centers
Lupus and APS Center of Excellence
Barbara Volcker Center for Women and Rheumatic Diseases
Integrative Rheumatology and Orthopedics Center
Procedures
Arthrocentesis
Intra-Articular Injections
Soft Tissue Injections
Patient Stories
Videos
Insurance
Please call our office if you have questions regarding your insurance coverage. If you have out of network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Attending Physician, Hospital for Special Surgery
Professor of Clinical Medicine, Weill Cornell Medical College
Affiliations
Multi Specialty Peer Review Committee (MSPRC), co chair
Quality Coordinating Committee
Professional Safety Committee
Director, Integrative Rheumatology and Orthopedics Center of Excellen
Medical Chief, Comprehensive Arthritis Program (CAP)
Director, CAP Research Program
Rehab Advisory Committee
Certification
American Board of Internal Medicine, 1980
American Board of Internal Medicine/Rheumatology, 1982
Awards
Castle Connolly Top Doctors in New York Metro Area, 2002-2022
New York Magazine Top Doctors, 2014, 2017, 2018, 2021, 2022
Education
MD, University of Cincinnati
Internship
Lenox Hill Hospital, New York
Residency
Lenox Hill Hospital, New York
Fellowship
Columbia-Presbyterian Medical Center, New York
State Licensure
Languages
English
Publications by Dr. Goodman
Patient Education
Professional Education
Blog Posts
Selected Journal Articles
American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity.
Desmarais J, Rosenbaum JT, Costenbader KH, Ginzler EM, Fett N, Goodman S, O'Dell J, Pineau CA, Schmajuk G, Werth VP, Link MS, Kovacs R.Arthritis Rheumatol. 2021 Oct 26. doi: 10.1002/art.41934. Online ahead of print.PMID: 34697918
Primary Care Provider Density and Elective Total Joint Replacement Outcomes.
Mehta B, Brantner C, Williams N, Szymonifka J, Navarro-Millan I, Mandl LA, Bass AR, Russell LA, Parks ML, Figgie MP, Nguyen JT, Ibrahim S, Goodman SM. Arthroplast Today. 2021 Jul 9;10:73-78. doi: 10.1016/j.artd.2021.05.010. eCollection 2021 Aug.PMID: 34527799 Free PMC article.
Use of Total Hip Arthroplasty in Patients Under 21 Years Old: A US Population Analysis.
Kahlenberg CA, Gibbons JAB, Jannat-Khah DP, Goodman SM, Mandl LA, Sculco PK, Goodman SB, Figgie MP, Mehta BY.J Arthroplasty. 2021 Aug 9:S0883-5403(21)00644-6. doi: 10.1016/j.arth.2021.08.004. Online ahead of print.PMID: 34456091
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis.
Balmuri N, Soulsby WD, Cooley V, Gerber L, Lawson E, Goodman S, Onel K, Mehta B; CARRA Registry Investigators,.Pediatr Rheumatol Online J. 2021 Aug 14;19(1):122. doi: 10.1186/s12969-021-00610-5.PMID: 34391453 Free PMC article.
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network.
Deonaraine KK, Carlucci PM, Fava A, Li J, Wofsy D, James JA, Putterman C, Diamond B, Davidson A, Fine DM, Monroy-Trujillo J, Atta MG, Haag K, Rao DA, Apruzzese W, Belmont HM, Izmirly PM, Wu M, Connery S, Payan-Schober F, Furie RA, Berthier CC, Dall'Era M, Cho K, Kamen DL, Kalunian K, Anolik J, Ishimori M, Weisman MH; Accelerating Medicines Partnership RA/SLE network, Petri MA, Buyon JP.Lupus Sci Med. 2021 Aug;8(1):e000522. doi: 10.1136/lupus-2021-000522.PMID: 34389634 Free PMC article.
Sequencing of Circulating Microbial Cell-Free DNA Can Identify Pathogens in Periprosthetic Joint Infections.
Echeverria AP, Cohn IS, Danko DC, Shanaj S, Blair L, Hollemon D, Carli AV, Sculco PK, Ho C, Meshulam-Simon G, Mironenko C, Ivashkiv LB, Goodman SM, Grizas A, Westrich GH, Padgett DE, Figgie MP, Bostrom MP, Sculco TP, Hong DK, Hepinstall MS, Bauer TW, Blauwkamp TA, Brause BD, Miller AO, Henry MW, Ahmed AA, Cross MB, Mason CE, Donlin LT.J Bone Joint Surg Am. 2021 Sep 15;103(18):1705-1712. doi: 10.2106/JBJS.20.02229.PMID: 34293751
Perioperative Glucocorticoids in Patients With Rheumatoid Arthritis Having Total Joint Replacements: Help or Harm?
Chukir T, Goodman SM, Tornberg H, Do H, Thomas C, Sigmund A, Sculco P, Figgie M, Mehta B, Russell L, Stein E.ACR Open Rheumatol. 2021 Sep;3(9):654-659. doi: 10.1002/acr2.11306. Epub 2021 Jul 20.PMID: 34288590 Free PMC article.
Assessment of Racial Disparities in the Risks of Septic and Aseptic Revision Total Knee Replacements.
Bass AR, Do HT, Mehta B, Lyman S, Mirza SZ, Parks M, Figgie M, Mandl LA, Goodman SM. JAMA Netw Open. 2021 Jul 1;4(7):e2117581. doi: 10.1001/jamanetworkopen.2021.17581.PMID: 34287631 Free PMC article.
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.
Tieu J, Cheah JT, Black RJ, Christensen R, Ghosh N, Richards P, Robson J, Shea B, Simon LS, Singhi JA, Tugwell P, Boers M, Garibay MAA, Campochiaro C, Decary S, de Witt M, Fernandez AP, Keen HI, King L, Hinojosa-Azaola A, Hofstetter C, Gaydukova I, George MD, Gupta L, Lyne S, Makol A, Mukhtyar C, Oo WM, Petri M, Pisaniello HL, Sattui SE, Russell O, Teixeira V, Toupin-April K, Uhunmwangho C, Whitstock M, Yip K, Mackie SL, Goodman SM, Hill CL.Semin Arthritis Rheum. 2021 Oct;51(5):1139-1145. doi: 10.1016/j.semarthrit.2021.06.010. Epub 2021 Jun 25.PMID: 34253398
Collaboration for the Management of Hydroxychloroquine.
Rosenbaum JT, Costenbader KH, Desmarais J, Ginzler EM, Fett N, Goodman SM, O'Dell JR, Schmajuk G, Werth VP, Melles RB, Marmor MF.Ophthalmology. 2021 Jul;128(7):1115-1116. doi: 10.1016/j.ophtha.2021.02.015. Epub 2021 Mar 19.PMID: 33752915 No abstract available.
Goodman SM. Rheumatoid arthritis: preoperative evaluation for total hip and total knee replacement surgery. J Clin Rheumatol 2013; Jun;19(4):187-92.
Goodman SM. Invited commentary. Sacroiliitis associated with axial spondyloarthropathy: new concepts and the latest trends. Radiographics 2013; Jul-Aug;33(4):956,8; discussion 959-61.
Goodman SM, Mackenzie CR. Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery. Curr Rheumatol Rep 2013; Sep;15(9):354,013-0354-y.
Johnson BK, Goodman SM, Alexiades MM, Figgie MP, Demmer RT, Mandl LA. Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement. J Rheumatol 2013; May;40(5):617-23.
Stundner O, Chiu YL, Sun X, Goodman SM, Russell LA, Calloway JJ, et al. Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study. Clin Exp Rheumatol 2013; Nov 14
Stundner O, Danninger T, Chiu YL, Sun X, Goodman SM, Russell LA, et al. Rheumatoid Arthritis vs Osteoarthritis in Patients Receiving Total Knee Arthroplasty: Perioperative Outcomes. J Arthroplasty 2013; Jun 11;.
Kim SS, Perino G, Boettner F, Miller A, Goodman S. Salmonella septic arthritis of the knees in a patient with systemic lupus erythematosus. Lupus 2013; Jun;22(7):740-3.
Goodman SM, Perez-Aso M, Cronstein B. Wound Healing and Anti-Rheumatic Agents. ACR Drug Safety Quarterly 2013; vol 4 (3)
Goodman SM, Mandl LA, Johnson B, Huang W-, Figgie MP, Alexiades M, Ghomrawi H. The Use of Biologic DMARDS Identifies Rheumatoid Arthritis Patients with More Optimistic Expectations of Total Knee Arthroplasty HSSJ in press
For more publications, please see the PubMed listing.
Research
Research Interests
perioperative outcomes of rheumatic disease patients undergoing arthroplasty
Clinical Trials
- The Established Rheumatoid Arthritis Cohort
- Perioperative Flare in Rheumatoid Arthritis: Characterization of Clinical and Biologic Features
- The PROMIS Rheumatoid Arthritis Longitudinal and Interview Study
- Do Rheumatoid Arthritis Patients Undergoing TKR And THR Require More Transfusions and Have More Pulmonary Disease than OA Controls?
- The RA Biodam Study: Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
- A Study of Novel Immune Modulating Biomarkers in Patients with Spondyloarthritis with Axial Involvement
- Do SLE Patients have more Early Adverse Events within 6 Months of THR and TKR?
- Biomarkers in Spondyloarthropathies: A Case Control Study
Industry Relationships
Industry Relationships
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Goodman as of November 19, 2021.
- American College of Rheumatology- Honoraria
- Horizon Therapeutics- Research Support
- Novartis- Consultant; Research Support
- UCB- consultant
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.